Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Brennan

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Transplantation|April 1, 2003
Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantationDaniel C Brennan
Seminars in Nephrology|October 25, 2016
Introduction: Kidney Transplantation and Viral InfectionDaniel C Brennan
Advances in Chronic Kidney Disease|January 18, 2006
Long-term trends in allograft survivalDaniel C Brennan
Journal of the American Society of Nephrology : JASN|November 7, 2025
Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE StudyDaniel C Brennan
Journal of the American Society of Nephrology : JASN|March 29, 2001
Cytomegalovirus in renal transplantationDaniel C Brennan
Expert Review of Anti-Infective Therapy|April 4, 2007
Prevention and management of cytomegalovirus infection in solid-organ transplantationKabeya Mwintshi, Daniel C Brennan
Advances in Experimental Medicine and Biology|April 22, 2006
BK virus and immunosuppressive agentsIrfan Agha, Daniel C Brennan
Medicina (Kaunas, Lithuania)|June 2, 2021
Donor-Derived Cell-Free DNA in Kidney Transplantation: Origins, Present and a Look to the FutureSam Kant, Daniel C Brennan
Transplantation|August 1, 2023
APOL1 Risk Alleles and Outcomes in Kidney Transplantation: Enter the RecipientSam Kant, Daniel C Brennan
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2014
Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?Siddiq Anwar, Daniel C Brennan
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Transplantation|April 1, 2003
Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantationDaniel C Brennan
Seminars in Nephrology|October 25, 2016
Introduction: Kidney Transplantation and Viral InfectionDaniel C Brennan
Advances in Chronic Kidney Disease|January 18, 2006
Long-term trends in allograft survivalDaniel C Brennan
Journal of the American Society of Nephrology : JASN|November 7, 2025
Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE StudyDaniel C Brennan
Journal of the American Society of Nephrology : JASN|March 29, 2001
Cytomegalovirus in renal transplantationDaniel C Brennan
Expert Review of Anti-Infective Therapy|April 4, 2007
Prevention and management of cytomegalovirus infection in solid-organ transplantationKabeya Mwintshi, Daniel C Brennan
Advances in Experimental Medicine and Biology|April 22, 2006
BK virus and immunosuppressive agentsIrfan Agha, Daniel C Brennan
Medicina (Kaunas, Lithuania)|June 2, 2021
Donor-Derived Cell-Free DNA in Kidney Transplantation: Origins, Present and a Look to the FutureSam Kant, Daniel C Brennan
Transplantation|August 1, 2023
APOL1 Risk Alleles and Outcomes in Kidney Transplantation: Enter the RecipientSam Kant, Daniel C Brennan
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2014
Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?Siddiq Anwar, Daniel C Brennan
Pageof 28